The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis, and treatment of endocrine disorders. Visit the below sections to learn more:
The legacy of Dr. Jerome Conn (former Division Chief of Metabolism, Endocrinology & Diabetes) includes his discovery of the syndrome that bears his name - listen to him describe it in his own words.
$30M Gift to Establish the Elizabeth Weiser Caswell Diabetes Institute at the University of Michigan
Martin Myers Jr., MD, PhD, director of the new institute, explains why this gift is important and how it will impact diabetes research.
Rodica Busui, MD, PhD finds that the use of continuous glucose monitoring by older adults reduced serious levels of hypoglycemia compared to using finger-stick test strips.
Richard Auchus, MD, PhD finds that adults with congenital adrenal hyperplasia who received crinecerfont experienced significant reductions in androgen levels with no serious adverse events.
- Facilitate and focus basic molecular and cellular research in all areas of metabolic and endocrine disorders.
- Promote the validation and application of relevant new basic knowledge in the clinical arena through rational, innovative and streamlined clinical, epidemiological and outcomes research.
- Evaluate, refine, and disseminate new clinical knowledge regarding diabetes and related disorders into community health practices, especially in those communities at increased risk.
- Recruit, train, motivate, and retain an effective pool of basic and clinical investigators and health care professional personnel in all areas of endocrinology and metabolism.
Committed to an internationally recognized mission of basic science research, the Division of Metabolism, Endocrinology & Diabetes conducts cutting-edge investigations in the areas of diabetes, obesity, thyroid, adrenal, pituitary, and neuroendocrine diseases. Studies are conducted at the molecular, cellular, and physiological levels, using a wide range of model systems.